-
全球糖尿病鞋类市场报告(2018-2025年)
This report studies the diabetic footwear market based on distribution channel, end users, type of footwear,
and region. Based on the type of distribution channel, the market is divided into online platform, specialty
store, footwear store, and others. Based on the end user type, the market is bifurcated into women and men.
Based on type of footwear, which includes shoes, sandals, and slippers. Based on region, the market is
analyzed across North America, Europe, Asia-Pacific, and LAMEA.
-
全球药物滥用检测市场
A drug test looks for the presence of one or more illegal or prescription drugs in your urine, blood, saliva, hair,
or sweat. Urine testing is the most commonly used sample type for drug screening.
The report covers the revenues associated with products as well as services used for drug screening purpose.
The key components of testing such as equipment, rapid testing devices, consumables, and laboratory services
are considered while deriving the revenues. However, the report excludes revenues generated by counseling
fees of doctors or healthcare providers who suggest various types of drug screening tests.
-
印度尼西亚制药和医疗保健行业报告(2018-2019年)
The pharmaceuticals and healthcare sector in Indonesia is at an early stage of development although
sectoral maturity has been growing in recent years. Industry development has been catalysed, to
some degree, by the rollout of the Indonesian government’s JKN programme that promises universal
healthcare to all Indonesians by 2019. This has significantly increased healthcare demand as more
patients become able to afford healthcare, and the higher demand has motivated the growth in
supply of healthcare services as well as medical devices and pharmaceuticals. In many cases in the
medical devices and pharmaceuticals subsectors, products are imported but the Indonesian
government has been seeking to increase the share of local production to reduce import dependence.
-
墨西哥制药和医疗保健行业报告(2019-2020年)
The level of competition in the pharma and healthcare sector varies across segments. A relatively
high degree of competition is observed in the pharmaceutical manufacturing, with 795 active
companies as of March 2018, of which 13% large enterprises with more than 250 employees. On the
other hand, as of the same month, there were 93,313 pharmacies in Mexico. Yet, the pharmaceutical
retail exhibits a moderate degree of competition, as five medium-sized chains accounted for 54.4% of
the drug retail sales in 2017. The health insurance in Mexico is virtually monopolised by the
government, with only a small private health insurance system offering some choice for consumers.
-
巴西制药和医疗保健行业报告(2018-2022年)
competition in Brazil’s pharma and healthcare sector is becoming increasingly intense. The
deceleration of the domestic drug market has propelled the pharmaceutical companies operating in
the country to search for scale and efficiency gains through organic growth, acquisitions and
internationalisation of their operations. The opening of the healthcare market to foreign investors in
January 2015 also unleashed a consolidation trend, triggered by the entry of both strategic and
institutional investors. Given the deficiencies in the provision of quality health services, healthcare
will remain the subsector with the highest growth potential in the medium term.